lenalidomide has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, JJ; Jia, HY; Qiu, HY; Wu, Y; Zhang, MD; Zhou, ML | 1 |
| Alaibac, M; Gnesotto, L; Mioso, G; Piaserico, S; Russo, I | 1 |
2 other study(ies) available for lenalidomide and Psoriasis
| Article | Year |
|---|---|
Lenalidomide attenuates IMQ-induced inflammation in a mouse model of psoriasis.
Topics: Animals; Disease Models, Animal; Imiquimod; Inflammation; Lenalidomide; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Psoriasis; Skin; Tumor Microenvironment | 2022 |
Exacerbation of psoriasis induced by lenalidomide in a patient with multiple myeloma.
Topics: Humans; Lenalidomide; Multiple Myeloma; Patients; Psoriasis; Thalidomide | 2023 |